Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid
NCT ID: NCT03055442
Last Updated: 2017-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2016-10-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment
NCT02385396
Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial
NCT04273256
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
NCT04163640
Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.
NCT03639506
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
NCT07020546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Follicular Fluids
Follicular fluids obtained by 8 oocyte donors
Dosage of myo-inositol
Quantitative analysis of myo-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Dosage of D-chiro-inositol
Quantitative analysis of D-chiro-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dosage of myo-inositol
Quantitative analysis of myo-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Dosage of D-chiro-inositol
Quantitative analysis of D-chiro-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* each specimen of follicular fluid containing only one oocyte.
Exclusion Criteria
* PCOS women also if euglycaemic;
* diabetic subjects having low concentrations of detectable MI in association with an anomalous MI transport.
18 Years
28 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lo.Li.Pharma s.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Iakentro Advanced Medical Centre, IVF Unit
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6. doi: 10.1093/humrep/17.6.1591.
Carlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. Epub 2011 Jun 8.
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000 Jun;73(6):1155-8. doi: 10.1016/s0015-0282(00)00518-5.
Ravanos K, Monastra G, Pavlidou T, Goudakou M, Prapas N. Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5491-5498. doi: 10.26355/eurrev_201712_13940.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MI/DCI_FF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.